A UCLA Health trial suggests cognitive behavioral therapy for insomnia may slow biological aging and improve rest in older adults compared to generic advice.
In September 2026, UCLA Health researchers reported that older adults completing cognitive behavioral therapy for insomnia showed higher remission rates and a slower pace of biological aging than peers receiving basic sleep education. The randomized controlled clinical trial, led by Dr. Judith Carroll, highlights a structured behavioral approach to healthy aging.
The study was a randomized controlled clinical trial involving 92 adults aged 60 and older. Participants were randomly assigned to either a structured cognitive behavioral therapy program or a standard sleep education therapy group. The control program provided general information about healthy sleep habits and environmental adjustments. It did not include the specific behavioral techniques that define the active therapy program.
The clinical intervention lasted for eight consecutive weeks. Researchers collected blood samples before the treatment began and during multiple follow-up visits over the next two years. The clinical results clearly favored the active behavioral approach over simple education. The study found that 34% of participants in the therapy group achieved full insomnia remission.
Only 13% of the control group reached that same outcome during the study period. UCLA Health noted that this difference represents a nearly three-fold greater likelihood of remission for the structured program. This outcome is highly relevant for broader public health and preventive medicine. UCLA Health estimates that clinical insomnia affects approximately 10% to 25% of U.S. adults over age 65.
The research team wanted to see if better rest influenced underlying physical biomarkers of aging. They used the collected blood samples to carefully analyze DNA methylation over time. The researchers applied three specific epigenetic aging measures known as DunedinPACE, GrimAge and PC-PhenoAge to track biological changes.
The statistically significant biological aging signal appeared on the DunedinPACE measure. This specific tool is designed to estimate the pace of aging rather than just chronological age. The slower pace recorded in the treated group led Dr. Carroll to a promising conclusion. She suggested that insomnia may be a modifiable risk factor for how the body ages over time.
Adults with persistent sleep issues can use this research to guide productive conversations with their medical providers. The American College of Physicians formally recommends cognitive behavioral therapy as the initial treatment for adults with chronic insomnia disorder. This clinical guideline supports prioritizing a non-drug treatment option before treating sleep problems with indefinite medication. The organization also recommends shared decision-making about medication when therapy alone is unsuccessful.
Patients should understand that this structured treatment focuses on the underlying thoughts and behaviors that maintain insomnia. It is much more involved than a simple handout on generic sleep hygiene. Earlier late-life insomnia research supports this focused approach over long-term drug use. That research found that behavioral treatment produced durable clinical gains at follow-up, whereas benefits from temazepam alone were not sustained after treatment ended.
Access to in-person therapy can sometimes be a logistical challenge for patients living outside major medical centers. A separate network meta-analysis found that alternative delivery formats can be highly effective for expanding access. Digital therapy platforms produced the largest reduction in symptom scores compared with standard treatment. Telephone delivery also showed significant benefits, which suggests that patients have multiple viable ways to access care.
Readers dealing with chronic nighttime awakenings should request a comprehensive medical evaluation before assuming insomnia is their only issue. Nighttime symptoms can often reflect sleep apnea, physical pain, frequent urination, restless legs or mood changes. A clinician should assess persistent or disruptive symptoms carefully to identify the true root cause. Treating an underlying physical condition is an important step in achieving better overall rest.
For those building a reliable daily routine, sleep improvement connects directly to lifestyle and brain resilience resources. A structured approach to rest fits perfectly into a broader cognitive health protection strategy. Prioritizing verified treatments over quick fixes helps older adults maintain their independence.
While the findings from UCLA Health are highly encouraging, readers must interpret them with a clear understanding of the limitations. The trial included only 92 participants and was conducted at a single site in Los Angeles. This limits how confidently the findings can be generalized to older adults from different regions, racial groups or clinical backgrounds. The researchers explicitly called for larger, multisite studies with more diverse participants to verify the results.
It is critical to understand what an epigenetic clock actually measures in a laboratory setting. These tools estimate biological aging characteristics based on complex DNA methylation patterns found in the blood. They do not directly measure a person's subjective age, brain performance or total remaining lifespan. The study result is most appropriately understood as evidence that treating insomnia may influence one specific biological marker.
The wider epigenetic aging field remains largely unsettled when it comes to measuring functional brain health. A 2026 Women's Health Initiative Memory Study found associations between several epigenetic clocks and exceptional longevity. None of the clocks was associated with cognitive healthspan in that particular analysis. A slower reading on a biological clock is a biomarker result, not a direct measurement of memory or attention.
Furthermore, the recent trial did not demonstrate that treating insomnia actively prevents Alzheimer's disease, cardiovascular disease or diabetes. The available report also does not establish that the therapy produced equivalent changes on the GrimAge or PC-PhenoAge scales. The statistically significant result was found specifically on the DunedinPACE measure. The reported biological aging effect was small, meaning it should be treated as promising early evidence rather than a definitive clinical conclusion.
This recent trial provides another compelling reason to address chronic sleep problems with structured professional support. Improving nighttime rest is about much more than simply feeling alert the following morning. Dr. Carroll pointed out that sleep is a health behavior worth targeting alongside physical activity and diet. A structured behavioral program offers a proven way to tackle persistent insomnia safely and effectively.
Older adults can view structured sleep interventions as a practical tool for maintaining long-term cognitive vitality. A systematic review and component network meta-analysis of 241 randomized trials recently highlighted the power of these programs. The review involved 31,452 adults and found that therapy components including cognitive restructuring were associated with better post-treatment remission outcomes. The average participant age in that review was 45.4 years so those specific findings are not exclusive to adults over 60.
Readers should set their immediate goal as achieving better sleep and reliable daily function. The idea of changing a biological clock is an interesting scientific concept, but improved daily functioning is the true practical benefit. Consistent sleep supports the mental clarity required for an active, engaged and purposeful life. The study does not establish whether this therapy is superior to all medications or other alternative treatments, as those comparisons require further research.
Anyone interested in the science of sleep and aging can read more brain aging and neuroplasticity articles on our site. Integrating healthy rest with thoughtful nutrition and purposeful learning is a central part of the FitBrainLab memory and focus philosophy. We encourage readers to discuss these proven behavioral interventions with their personal physicians to find a suitable approach.
Treating chronic sleep issues with generic advice or long-term medication often leaves older adults feeling frustrated, and FitBrainLab translates proven clinical interventions so you can focus on verified behavioral strategies. Managing conflicting advice about sleep and brain performance creates unnecessary confusion, but we provide clear editorial guidance so you can approach nighttime rest objectively.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
